Father Recalls Nightmarish Moment Son Fell Down 120-Foot Ledge While Hallucinating On Hike
Zane Wach, 14, has been in a medically induced coma since being rescued from California's Mount Whitney where he and his father, Ryan Wach, had been hiking June 10.
In an interview with SF Gate published last week, Ryan Wach said Zane Wach ― a regular distance runner who competes in triathlons and has had a lot of past hiking experience ― was exhibiting symptoms of altitude sickness and had begun speaking erratically.
'He started to experience some hallucinations,' Ryan Wach recalled, noting that the two were partway through their descent down the mountain. 'He knew he was hallucinating. He said he saw things like snowmen and Kermit the Frog.'
Watch a News 3 Las Vegas interview with Ryan Wach below.
He went on to note: 'He was in an altered mental state, and I don't know what caused it. We still don't know. My best guess is a combination of exhaustion, sleep deprivation, probably some dehydration and lasting effects from the altitude sickness. But he essentially started to doubt reality.'
In a separate interview with NBC affiliate News 3 Las Vegas, Ryan Wach said Zane Wach 'believed that we had finished the hike multiple times already in his mind, like he was not present any longer,' adding: 'I heard steps to my right, and he was walking off the ledge.'
Immediately after Zane Wach's fall, Ryan Wach ran to the spot where his son had landed while a nearby hiker began coordinating rescue efforts. It took about six hours in total for rescue teams to arrive, after which Zane Wach was transported to California's Southern Inyo Hospital and, later, to Sunrise Children's Hospital in Las Vegas. Though the teen sustained head trauma, he was spared any major bodily injuries in the fall save for a broken ankle, a broken finger and a partially broken pelvis.
Zane Wach had his ventilators removed and resumed breathing on his own last week. Though the Wach family remains hopeful for a full recovery, Ryan Wach told SF Gate: 'It's going to be a survival story in the end, but right now we're still in the middle of it.'
Man Arrested 10 Months After Mom Of 5 Killed Along Popular Hiking Trail
Former College Ski Racing Champion Dead At 26
We Never Felt Welcomed On The Trails. But That's All About To Change.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Mizuho Raises Boston Scientific (BSX) Price Target as Robotics and Devices Drive Growth
Boston Scientific Corporation (NYSE:BSX) ranks among the . Mizuho kept its Outperform rating on Boston Scientific Corporation (NYSE:BSX), and increased its price target for the medical device maker from $130 to $140 on July 24. The firm reported that the global recall of the ACURATE transcatheter aortic valve replacement (TAVR) system in the second half of the year was expected to be compensated by solid performance in Boston Scientific's FARAPULSE and WATCHMAN product lines. While Boston Scientific Corporation (NYSE:BSX) has no plans to re-engineer the ACURATE valve, putting it 'at square one in the TAVR space,' the company is still on track to acquire clearances for FARAPULSE in China and Japan before the end of the year, according to Mizuho's research. Boston Scientific Corporation (NYSE:BSX) is a global leader in the manufacture of medical devices, including stents, brain stimulation systems, heart monitors, and catheters. A leading name in robotics, the company has made great strides in the humanoid aspect of the industry with its two-legged Atlas robot. While we acknowledge the potential of BSX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BSX and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Fox News
23 minutes ago
- Fox News
WATCH LIVE: Will Cain weighs in on Cracker Barrel's minimalist rebrand
Dr. Ann Shippy also joins the show to discuss America's reproductive health problem and its impact on our youth.
Yahoo
an hour ago
- Yahoo
Serena Williams reveals she's using weight loss drugs and addresses stigma
Serena Williams is sharing how she took a swing at weight loss drugs. The tennis legend, 43, explained she "hit a wall" she had never encountered before after having her kids in a campaign video for telehealth company Ro. "I was doing everything right — working out, eating clean, following the plan. But my body wasn't responded the way it used to. I knew my body was missing something it needed," she said in the ad. The answer for her, she continued, was GLP-1s. According to the campaign, Williams has lost 31 pounds in 8 months using GLP-1s, though it is unclear which drug she has used. The campaign noted she used another GLP-1 provider before Ro, which currently offers Zepbound, Ozempic, Wegovy and Saxenda. Drugs known as GLP-1 receptor agonists mimic a hormone in the body known as glucagon-like peptide 1, which helps signal fullness to the brain and regulate blood sugar. Ozempic is typically used for diabetes while Saxenda, Wegovy and Zepbound are approved for weight loss. Williams, now a celebrity patient ambassador for Ro, also spoke to the stigma surrounding the popular weight loss drugs. "If you're on GLP-1s too, don't let anybody tel you it's the 'easy way out.' You're not taking a shortcut, you're taking care of yourself, and that takes courage," she said. In an interview with People magazine Thursday, Williams said she feels "really good and healthy." "I feel light physically and light mentally," she told the magazine. "I just can do more. I'm more active. My joints don't hurt as much. I just feel like something as simple as just getting down is a lot easier for me. And I do it a lot faster." This isn't the first famous face to open up about their use of the medications. In 2023, Oprah Winfrey revealed she turned to a weight-loss medication after years of struggling with her weight. Videos on social media showing dramatic transformations have also increased demand in recent years. The medications don't come without risks, however. For example, the most common side effects of Ozempic are nausea, stomach pain, constipation, diarrhea and vomiting, according to the drug's website. Some people have reported severe GI-related issues, including gastroparesis, a paralysis of the stomach also called delayed gastric emptying. This condition is the basis of a lawsuit filed in 2023, which claims the drug makers failed to warn consumers. And long-term, it's unclear how these drugs will affect the body. Trump sounds off on potential security guarantees for Ukraine Creative school lunch ideas for kids who are picky eaters Tennis star Daria Kasatkina embraces new life in Australia ahead of U.S. Open Solve the daily Crossword
